Abstract
Natural products from plants are still important sources for the
development of drugs, despite their recent neglect in pharmaceutical
discovery programmes. The rapidly dwindling number of species endangers
the availability of these natural compounds, which are characterized by
the immense chemical and functional diversity ultimately responsible for
their pharmaceutical activity. Although many steps in the drug
discovery process have been continuously modified during recent years, a
common dilemma is still unresolved, i.e. the supply crisis for hits
discovered in rare wild plants due to their inaccessibility or lack of
reproducibility. New technology, combining tissue culture, functional
genomics and metabolomics, shows promise to overcome these problems and
even to supply a greater chemical diversity of compounds.
Original language | English |
---|---|
Pages (from-to) | 83 - 89 |
Number of pages | 7 |
Journal | Plant Genetic Resources: Characterisation and Utilisation |
Volume | 3 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2005 |
MoE publication type | A1 Journal article-refereed |
Keywords
- cell cultures
- combinatorial biochemistry
- functional genomics
- metabolomics
- plant-derived pharmaceuticals